|
1
|
Bray F, Laversanne M, Sung H, Ferlay J,
Siegel RL, Soerjomataram I and Jemal A: Global cancer statistics
2022: GLOBOCAN estimates of incidence and mortality worldwide for
36 cancers in 185 countries. CA Cancer J Clin. 74:229–263.
2024.PubMed/NCBI
|
|
2
|
Áyen Á, Jiménez Martínez Y and Boulaiz H:
Targeted gene delivery therapies for cervical cancer. Cancers
(Basel). 12:13012020. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Yan H, Wang P, Yang F, Cheng W, Chen C,
Zhai B and Zhou Y: Anticancer therapy-induced adverse drug
reactions in children and preventive and control measures. Front
Pharmacol. 15:13292202024. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Ruttkay-Nedecky B, Jimenez Jimenez AM,
Nejdl L, Chudobova D, Gumulec J, Masarik M, Adam V and Kizek R:
Relevance of infection with human papillomavirus: the role of the
p53 tumor suppressor protein and E6/E7 zinc finger proteins
(review). Int J Oncol. 43:1754–1762. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Chew YC, Adhikary G, Wilson GM, Xu W and
Eckert RL: Sulforaphane induction of p21(Cip1) cyclin-dependent
kinase inhibitor expression requires p53 and Sp1 transcription
factors and is p53-dependent. J Biol Chem. 287:16168–16178. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Fu H, Wang C, Yang D, Wei Z, Xu J, Hu Z,
Zhang Y, Wang W, Yan R and Cai Q: Curcumin regulates proliferation,
autophagy, and apoptosis in gastric cancer cells by affecting PI3K
and P53 signaling. J Cell Physiol. 233:4634–4642. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Younas M, Hano C, Giglioli-Guivarc'h N and
Abbasi BH: Mechanistic evaluation of phytochemicals in breast
cancer remedy: Current understanding and future perspectives. RSC
Adv. 8:29714–29744. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Hamdan AME, Alharthi FHJ, Alanazi AH,
El-Emam SZ, Zaghlool SS, Metwally K, Albalawi SA, Abdu YS, Mansour
RE, Salem HA, et al: Neuroprotective effects of phytochemicals
against aluminum chloride-induced Alzheimer's disease through
ApoE4/LRP1, Wnt3/β-Catenin/GSK3β, and TLR4/NLRP3 pathways with
physical and mental activities in a rat model. Pharmaceuticals
(Basel). 15:10082022. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Sohel M, Aktar S, Biswas P, Amin MA,
Hossain MA, Ahmed N, Mim MIH, Islam F and Mamun AA: Exploring the
anti-cancer potential of dietary phytochemicals for the patients
with breast cancer: A comprehensive review. Cancer Med.
12:14556–14583. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Paudel S, Mishra N and Agarwal R:
Phytochemicals as immunomodulatory molecules in cancer
therapeutics. Pharmaceuticals (Basel). 16:16522023. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Chen S, Wang X, Cheng Y, Gao H and Chen X:
A review of classification, biosynthesis, biological activities and
potential applications of flavonoids. Molecules. 28:49822023.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Hosseinzadeh A, Poursoleiman F, Biregani
AN and Esmailzadeh A: Flavonoids target different molecules of
autophagic and metastatic pathways in cancer cells. Cancer Cell
Int. 23:1142023. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Kopustinskiene DM, Jakstas V, Savickas A
and Bernatoniene J: Flavonoids as anticancer agents. Nutrients.
12:4572020. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
An JP, Liu X, Kim D, Madden R and Wang Y:
Comprehensive analysis of polymethoxyflavone metabolism in orange
peel using an animal model. RSC Adv. 15:38189–38200. 2025.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Wang Y, Mou Y, Lu S, Xia Y and Cheng B:
Polymethoxylated flavonoids in citrus fruits: Absorption,
metabolism, and anticancer mechanisms against breast cancer. PeerJ.
12:e167112024. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Raza W, Luqman S and Meena A: Prospects of
tangeretin as a modulator of cancer targets/pathways. Pharmacol
Res. 161:1052022020. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Hung WL, Chang WS, Lu WC, Wei GJ, Wang Y,
Ho CT and Hwang LS: Pharmacokinetics, bioavailability, tissue
distribution and excretion of tangeretin in rat. J Food Drug Anal.
26:849–857. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Dey DK, Chang SN, Vadlamudi Y, Park JG and
Kang SC: Synergistic therapy with tangeretin and 5-fluorouracil
accelerates the ROS/JNK mediated apoptotic pathway in human
colorectal cancer cell. Food Chem Toxicol. 143:1115292020.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Dong Y, Cao A, Shi J, Yin P, Wang L, Ji G,
Xie J and Wu D: Tangeretin, a citrus polymethoxyflavonoid, induces
apoptosis of human gastric cancer AGS cells through extrinsic and
intrinsic signaling pathways. Oncol Rep. 31:1788–1794. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Xie Y, Feng SL, He F, Yan PY, Yao XJ, Fan
XX, Leung EL and Zhou H: Down-regulating Nrf2 by tangeretin
reverses multiple drug resistance to both chemotherapy and EGFR
tyrosine kinase inhibitors in lung cancer. Pharmacol Res.
186:1065142022. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Varankar SS and Bapat SA: Migratory
metrics of wound healing: A quantification approach for in vitro
scratch assays. Front Oncol. 8:6332018. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Ibrahim SM, Bakhashab S, Ilyas AM,
Pushparaj PN, Karim S, Khan JA, Abuzenadah AM, Chaudhary AG,
Al-Qahtani MH and Ahmed F: WYE-354 restores Adriamycin sensitivity
in multidrug-resistant acute myeloid leukemia cell lines. Oncol
Rep. 41:3179–3188. 2019.PubMed/NCBI
|
|
23
|
Atchan APN, Monthe OC, Tchamgoue AD, Singh
Y, Shivashankara ST, Selvi MK, Agbor GA, Magni P, Piazza S,
Manjappara UV, et al: Anti-inflammatory, antioxidant activities,
and phytochemical characterization of edible plants exerting
synergistic effects in human gastric epithelial cells. Antioxidants
(Basel). 12:5912023. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Lin JJ, Huang CC, Su YL, Luo HL, Lee NL,
Sung MT and Wu YJ: Proteomics analysis of tangeretin-induced
apoptosis through mitochondrial dysfunction in bladder cancer
cells. Int J Mol Sci. 20:10172019. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Zhang X, Zheng L, Sun Y, Wang T and Wang
B: Tangeretin enhances radiosensitivity and inhibits the
radiation-induced epithelial-mesenchymal transition of gastric
cancer cells. Oncol Rep. 34:302–310. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Jeoung YH, Lee HK, Ahn SH, Bhutta ZA and
Choi KC: Tangeretin induces apoptosis and cell cycle arrest in
thyroid cancer cells. Toxicol Res. 41:477–488. 2025. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Surichan S, Arroo RR, Tsatsakis AM and
Androutsopoulos VP: Tangeretin inhibits the proliferation of human
breast cancer cells via CYP1A1/CYP1B1 enzyme induction and
CYP1A1/CYP1B1-mediated metabolism to the product 4′ hydroxy
tangeretin. Toxicol In Vitro. 50:274–284. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Schegoleva AA, Khozyainova AA,
Gerashchenko TS, Zhuikova LD and Denisov EV: Metastasis prevention:
Targeting causes and roots. Clin Exp Metastasis. 39:505–519. 2022.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Ting YW, Chiou YS, Pan MH, Ho CT and Huang
QR: In vitro and in vivo anti-cancer activity of tangeretin against
colorectal cancer was enhanced by emulsion-based delivery system. J
Funct Foods. 15:264–273. 2015. View Article : Google Scholar
|
|
30
|
Li X, Li Q, Huang Y, Zhou H, Yang Q and
Kong L: Quercetin, a natural dietary flavonoid, emerges a novel
USP7 inhibitor with anti-colorectal cancer effects. Biol Pharm
Bull. 48:1485–1492. 2025. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Kang KA, Piao MJ, Hyun YJ, Zhen AX, Cho
SJ, Ahn MJ, Yi JM and Hyun JW: Luteolin promotes apoptotic cell
death via upregulation of Nrf2 expression by DNA demethylase and
the interaction of Nrf2 with p53 in human colon cancer cells. Exp
Mol Med. 51:1–14. 2019. View Article : Google Scholar
|
|
32
|
Jung EJ, Lee WS, Paramanantham A, Kim HJ,
Shin SC, Kim GS, Jung JM, Ryu CH, Hong SC, Chung KH and Kim CW: p53
Enhances Artemisia annua L. Polyphenols-induced cell death through
upregulation of p53-dependent targets and cleavage of PARP1 and
lamin A/C in HCT116 colorectal cancer cells. Int J Mol Sci.
21:93152020. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Alshehri A, Ahmad A, Tiwari RK, Ahmad I,
Alkhathami AG, Alshahrani MY, Asiri MA, Almeleebia TM, Saeed M,
Yadav DK and Ansari IA: In vitro evaluation of antioxidant,
anticancer, and anti-inflammatory activities of ethanolic leaf
extract of Adenium obesum. Front Pharmacol. 13:8475342022.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Pandey BP, Adhikari K, Pradhan SP, Shin
HJ, Lee EK and Jung HJ: In-vitro antioxidant, anti-cancer, and
anti-inflammatory activities of selected medicinal plants from
western Nepal. Futur J Pharm Sci. 6:752020. View Article : Google Scholar
|
|
35
|
Ko YC, Choi HS, Liu R, Kim JH, Kim SL, Yun
BS and Lee DS: Inhibitory effects of tangeretin, A citrus
peel-derived flavonoid, on breast cancer stem cell formation
through suppression of Stat3 signaling. Molecules. 25:25992020.
View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Zhu WB, Xiao N and Liu XJ: Dietary
flavonoid tangeretin induces reprogramming of epithelial to
mesenchymal transition in prostate cancer cells by targeting the
PI3K/Akt/mTOR signaling pathway. Oncol Lett. 15:433–440.
2018.PubMed/NCBI
|
|
37
|
Morley KL, Ferguson PJ and Koropatnick J:
Tangeretin and nobiletin induce G1 cell cycle arrest but not
apoptosis in human breast and colon cancer cells. Cancer Lett.
251:168–178. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Pan MH, Chen WJ, Lin-Shiau SY, Ho CT and
Lin JK: Tangeretin induces cell-cycle G1 arrest through inhibiting
cyclin-dependent kinases 2 and 4 activities as well as elevating
Cdk inhibitors p21 and p27 in human colorectal carcinoma cells.
Carcinogenesis. 23:1677–1684. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Hui San S and Ching Ngai S: E-cadherin
re-expression: Its potential in combating TRAIL resistance and
reversing epithelial-to-mesenchymal transition. Gene.
909:1482932024. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Lin WH, Cooper LM and Anastasiadis PZ:
Cadherins and catenins in cancer: Connecting cancer pathways and
tumor microenvironment. Front Cell Dev Biol. 11:11370132023.
View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Mani SA, Guo W, Liao MJ, Eaton EN, Ayyanan
A, Zhou AY, Brooks M, Reinhard F, Zhang CC, Shipitsin M, et al: The
epithelial-mesenchymal transition generates cells with properties
of stem cells. Cell. 133:704–715. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Vega S, Morales AV, Ocaña OH, Valdés F,
Fabregat I and Nieto MA: Snail blocks the cell cycle and confers
resistance to cell death. Genes Dev. 18:1131–1143. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Mustafa M, Ahmad R, Tantry IQ, Ahmad W,
Siddiqui S, Alam M, Abbas K, Moinuddin Hassan MI, Habib S and Islam
S: Apoptosis: A comprehensive overview of signaling pathways,
morphological changes, and physiological significance and
therapeutic implications. Cells. 13:18382024. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Vogler M, Braun Y, Smith VM, Westhoff MA,
Pereira RS, Pieper NM, Anders M, Callens M, Vervliet T, Abbas M, et
al: The BCL2 family: From apoptosis mechanisms to new advances in
targeted therapy. Signal Transduct Target Ther. 10:912025.
View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Heo JW, No MH, Park DH, Kang JH, Seo DY,
Han J, Neufer PD and Kwak HB: Effects of exercise on
obesity-induced mitochondrial dysfunction in skeletal muscle.
Korean J Physiol Pharmacol. 21:567–577. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Roy MJ, Vom A, Czabotar PE and Lessene G:
Cell death and the mitochondria: Therapeutic targeting of the BCL-2
family-driven pathway. Br J Pharmacol. 171:1973–1987. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Khan T, Waseem R, Zehra Z, Aiman A,
Bhardwaj P, Ansari J, Hassan MI and Islam A: Mitochondrial
dysfunction: Pathophysiology and mitochondria-targeted drug
delivery approaches. Pharmaceutics. 14:26572022. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Wang H, Guo M, Wei H and Chen Y: Targeting
p53 pathways: Mechanisms, structures, and advances in therapy.
Signal Transduct Target Ther. 8:922023. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Rastogi N, Duggal S, Singh SK, Porwal K,
Srivastava VK, Maurya R, Bhatt ML and Mishra DP: Proteasome
inhibition mediates p53 reactivation and anti-cancer activity of
6-gingerol in cervical cancer cells. Oncotarget. 6:43310–43325.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Zhao X, Sun W, Ren Y and Lu Z: Therapeutic
potential of p53 reactivation in cervical cancer. Crit Rev Oncol
Hematol. 157:1031822021. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Wang JCK, Baddock HT, Mafi A, Foe IT,
Bratkowski M, Lin TY, Jensvold ZD, Preciado López M, Stokoe D,
Eaton D, et al: Structure of the p53 degradation complex from
HPV16. Nat Commun. 15:18422024. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Zou J, Li Y, Chen T and Zhu C: An
E7-retinoblastoma protein pathway mechanism may account for the
higher carcinogenic ability of HPV16 over HPV58 in cervical cancer.
Transl Cancer Res. 13:1876–1886. 2024. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Wang W, Jia T, Zhang Y and Zhou Y:
Progress of researches on pharmacological effects and
bioavailability of tangeretin. J Oleo Sci. 74:13–23. 2025.
View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Woo SH, Park IC, Park MJ, Lee HC, Lee SJ,
Chun YJ, Lee SH, Hong SI and Rhee CH: Arsenic trioxide induces
apoptosis through a reactive oxygen species-dependent pathway and
loss of mitochondrial membrane potential in HeLa cells. Int J
Oncol. 21:57–63. 2002.PubMed/NCBI
|
|
55
|
Elhennawy MG and Lin HS: Determination of
tangeretin in rat plasma: Assessment of its clearance and absolute
oral bioavailability. Pharmaceutics. 10:32017. View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Hu Y, Liu F, Pang J, McClements DJ, Zhou
Z, Li B and Li Y: Biopolymer additives enhance tangeretin
bioavailability in emulsion-based delivery systems: an in vitro and
in vivo study. J Agric Food Chem. 69:730–740. 2021. View Article : Google Scholar : PubMed/NCBI
|
